CME: Updates in vaccine-preventable diseases: meningococcal meningitis
Cost: FreeView Offer chevron_right
Meningococcal disease is a potentially severe bacterial infection caused by Neisseria meningitidis that may lead to serious sequelae and death in some even with appropriate treatment. N. meningitidis is a leading cause of bacterial meningitis and sepsis in the United States. Since the peak of the disease in the late 1990s, the incidence has declined annually and was at historic low rate of 0.11 per 100,000 population (349 cases) in the year 2017. Among the identified bacterial serogroups, B, C, and Y cause the majority of cases in the United States. Sixty percent of cases among patients 0-59 months and 50% of cases among 17-23 years of age are caused by serogroup B. Seventy-three percent of all cases among eleven year old or more are caused by serogroups C, W, or Y.
By the end of the session the participant will be able to:
- Recall epidemiology, clinical features, and complications of meningococcal meningitis
- Recognize high-risk groups (e.g., 16-23 years of age) and describe the importance of immunizing them
- Describe present meningococcal vaccination recommendations, and apply them to patient cases
- Describe the importance of vaccine series completion to patients in the prevention of invasive meningococcal disease caused by various serotypes
- Formulate an approaches to engaging with adolescents and young adults regarding meningococcal vaccination
The following HCPs: primary care physicians, pediatricians, and public health professionals; physician assistants, nurse practitioners, nurses, and pharmacists who practice in family medicine; and any other clinicians with an interest in or who commonly encounter patients eligible for vaccination against meningococcal disease.